CD34 and neoplasm: Haemangiogenesis was then more specifically determined by immunohistochemistry with a CD34 antibody detecting a glycoprotein on the surface of vascular endothelial cells in MiaPaCa-2-TREx-TP53 tumours that were grown for 8 weeks.